ASRT Assertio Holdings, Inc. Stock Quote

Your browser is no longer supported. Please, upgrade your browser.

publish chart | save to portfolio | create alert

Settings

ASRT [NASD]

Assertio Holdings, Inc.

Healthcare | Drug Manufacturers - Specialty & Generic | USA

statements

Index	-	P/E	-	EPS (ttm)	-1.97	Insider Own	3.40%	Shs Outstand	70.94M	Perf Week	2.60%
Market Cap	89.42M	Forward P/E	5.58	EPS next Y	0.15	Insider Trans	-0.43%	Shs Float	61.33M	Perf Month	-9.01%
Income	-161.70M	PEG	-	EPS next Q	-0.03	Inst Own	64.30%	Short Float	2.81%	Perf Quarter	-6.97%
Sales	192.50M	P/S	0.46	EPS this Y	-634.30%	Inst Trans	23.37%	Short Ratio	1.19	Perf Half Y	-27.82%
Book/sh	1.18	P/B	0.71	EPS next Y	36.36%	ROA	-27.90%	Target Price	-	Perf Year	-74.39%
Cash/sh	-	P/C	-	EPS next 5Y	25.00%	ROE	-110.00%	52W Range	0.55 - 3.55	Perf YTD	-33.02%
Dividend	-	P/FCF	2.44	EPS past 5Y	-28.50%	ROI	-39.80%	52W High	-76.41%	Beta	2.15
Dividend %	-	Quick Ratio	1.50	Sales past 5Y	-10.10%	Gross Margin	95.70%	52W Low	52.24%	ATR	0.06
Employees	125	Current Ratio	1.50	Sales Q/Q	-63.90%	Oper. Margin	-55.90%	RSI (14)	49.33	Volatility	4.87% 7.18%
Optionable	Yes	Debt/Eq	0.69	EPS Q/Q	360.70%	Profit Margin	-84.00%	Rel Volume	0.48	Prev Close	0.81
Shortable	Yes	LT Debt/Eq	0.00	Earnings	May 11 BMO	Payout	-	Avg Volume	1.44M	Price	0.84
Recom	2.00	SMA20	-1.32%	SMA50	-4.24%	SMA200	-13.09%	Volume	685,403	Change	2.80%

Nov-30-18

Downgrade

Mizuho

Buy → Neutral

Jul-08-20 07:00AM	Maple Leaf Foods Releases 2019 Sustainability Report PR Newswire
Jun-30-20 11:50PM	Should You Avoid Assertio Holdings, Inc. (ASRT)? Insider Monkey
Jun-24-20 06:27PM	Maple Leaf Foods Inc. Announces Results of Vote For Election of Directors PR Newswire
May-22-20 07:24AM	STOCKHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Assertio Therapeutics, Inc. - ASRT PR Newswire -6.19%
May-21-20 06:30AM	Maple Leaf Foods Receives TSX Approval To Proceed With Normal Course Issuer Bid PR Newswire
May-20-20 06:20PM	Maple Leaf Foods Management Information Circular Now Available PR Newswire +13.01%
08:48AM	Assertio Completed Merger with Zyla Life Sciences PR Newswire
May-17-20 08:09AM	One Analyst's Earnings Estimates For Assertio Therapeutics, Inc. (NASDAQ:ASRT) Are Surging Higher Simply Wall St.
May-11-20 10:35AM	Assertio (ASRT) Beats Q1 Earnings and Revenue Estimates Zacks +8.98%
08:17AM	Recap: Assertio Therapeutics Q1 Earnings Benzinga
08:00AM	Assertio Therapeutics Announces First-Quarter 2020 Results GlobeNewswire
May-08-20 10:41PM	SHAREHOLDER ALERT: Halper Sadeh LLP Investigates The Merger Of Assertio Therapeutics, Inc.; Investors Are Encouraged To Contact The Firm PR Newswire
10:10PM	ASSERTIO MERGER INVESTIGATION: Halper Sadeh LLP Announces Investigation Into Whether The Merger Of Assertio Therapeutics, Inc. Is Fair To Shareholders; Investors Are Encouraged To Contact The Firm ACCESSWIRE
07:02PM	SHAREHOLDER ALERT: WeissLaw LLP Investigates Assertio Therapeutics, Inc. PR Newswire
May-06-20 12:30PM	Analysts Estimate Assertio (ASRT) to Report a Decline in Earnings: What to Look Out for Zacks
Apr-30-20 12:00PM	All You Need to Know About Assertio (ASRT) Rating Upgrade to Buy Zacks
Apr-20-20 05:08PM	Assertio Therapeutics Announces its Virtual 2020 Annual Meeting on May 19, 2020, and Mailing of its Joint Proxy Statement/Prospectus GlobeNewswire
Apr-08-20 04:05PM	Assertio Therapeutics Announces Completion and Final Results of the Offer to Purchase All of Its Issued and Outstanding 2.50% Senior Convertible Notes due 2021 and 5.00% Senior Convertible Notes due 2024 GlobeNewswire
Apr-02-20 06:24AM	Does Assertio Therapeutics, Inc. (NASDAQ:ASRT) Have A Particularly Volatile Share Price? Simply Wall St.
Mar-17-20 11:41AM	Wayne-based drug company enters into $17.5M merger deal American City Business Journals
10:15AM	Are Shareholders Getting a Fair Deal? Halper Sadeh LLP Investigates the Sale of These Companies WLTW, TTPH, ASRT, MEET GlobeNewswire
Mar-16-20 06:45PM	Assertio Therapeutics Agrees to Merge with Zyla Life Sciences to Create Synergistic Portfolio of Neurology and Non-Opioid Pain Products GlobeNewswire -6.25%
Mar-11-20 01:01AM	Assertio Therapeutics Announces Offer to Purchase All of Its Issued and Outstanding 2.50% Senior Convertible Notes Due 2021 and 5.00% Senior Convertible Notes Due 2024 GlobeNewswire +25.67%
Mar-09-20 05:55PM	Assertio (ASRT) Reports Q4 Loss, Tops Revenue Estimates Zacks -6.14%
04:02PM	Assertio Therapeutics Announces Fourth-Quarter and Full-Year 2019 Financial Results GlobeNewswire
02:30AM	Assertio Therapeutics, Inc. to Host Earnings Call ACCESSWIRE
Mar-08-20 04:14PM	The Week Ahead In Biotech (March 8-14): Bristol-Myers Awaits FDA Nod For Liver Cancer Combo Therapy, Earnings Flow Continues Benzinga
Mar-02-20 05:30PM	Assertio Therapeutics to Report Fourth Quarter and Full Year 2019 Financial Results After the Close of Markets on Monday, March 9, 2020 GlobeNewswire
Feb-26-20 12:30PM	Analysts Estimate Assertio (ASRT) to Report a Decline in Earnings: What to Look Out for Zacks
Feb-24-20 10:33AM	Assertio (ASRT) to Report Q4 Earnings: What's in Store? Zacks -10.69%
Feb-19-20 08:00AM	Assertio Therapeutics Announces Repurchase of Approximately $188.0 Million of its Outstanding Convertible Debt GlobeNewswire +6.98%
Feb-17-20 06:00AM	Did Changing Sentiment Drive Assertio Therapeutics's (NASDAQ:ASRT) Share Price Down A Painful 93%? Simply Wall St.
Feb-14-20 08:23AM	The Daily Biotech Pulse: Epizyme's Tazemetostat sNDA Accepted For Priority Review, Eisai To Withdraw Weight Loss Drug, Sol-Gel Prices Offering Benzinga
Feb-13-20 04:05PM	Assertio Therapeutics Announces Closing of Sale of NUCYNTA® Franchise to Collegium Pharmaceutical for $375.0 Million GlobeNewswire
Feb-07-20 07:32AM	The Daily Biotech Pulse: Assertio To Sell Opioid Pain Drug, Milestone Payment For Aduro, Myriad Genetics CEO Resigns Benzinga +46.15%
Feb-06-20 04:01PM	Assertio Therapeutics Announces Sale of NUCYNTA® Franchise to Collegium Pharmaceutical for $375.0 Million GlobeNewswire
Feb-04-20 05:45PM	Assertio (ASRT) Gains But Lags Market: What You Should Know Zacks
Jan-29-20 05:45PM	Assertio (ASRT) Dips More Than Broader Markets: What You Should Know Zacks
Jan-22-20 11:30AM	Is ASSERTIO THERAPEUTICS, INC (ASRT) Outperforming Other Medical Stocks This Year? Zacks
Jan-15-20 05:45PM	Assertio (ASRT) Stock Sinks As Market Gains: What You Should Know Zacks
Jan-13-20 11:40AM	ASRT or PCRX: Which Is the Better Value Stock Right Now? Zacks
07:50AM	Assertio Therapeutics Announces Closing of Gralise® Sale to Alvogen and Expects Full-Year 2019 Neurology Franchise Net Sales Above Upper End of Prior Guidance GlobeNewswire
Jan-09-20 05:45PM	Assertio (ASRT) Stock Sinks As Market Gains: What You Should Know Zacks
Jan-08-20 10:18AM	Tyme Out-Licenses Cancer Candidate to Eagle Pharma, Stock Up Zacks -6.09%
Jan-07-20 09:51AM	Intrexon's Blood Cancer Drug Gets Orphan Drug Status From FDA Zacks +6.48%
09:17AM	Catalyst Gives Preliminary Firdapse Estimates & Other Updates Zacks
Dec-27-19 11:40AM	ASRT vs. PCRX: Which Stock Is the Better Value Option? Zacks
Dec-23-19 12:00PM	Assertio (ASRT) Upgraded to Strong Buy: What Does It Mean for the Stock? Zacks
Dec-19-19 06:40AM	Need To Know: Assertio Therapeutics, Inc. (NASDAQ:ASRT) Insiders Have Been Buying Shares Simply Wall St.
Dec-13-19 03:07PM	Hedge Funds Are Crazy About Assertio Therapeutics, Inc. (ASRT) Insider Monkey
08:39AM	Assertio to Divest Shingles Pain Drug to Alvogen for $127.5M Zacks
Dec-12-19 07:50AM	Assertio Therapeutics Announces Sale of Gralise® for Total Transaction Value of $127.5 Million GlobeNewswire +56.65%
Dec-10-19 11:40AM	ASRT vs. PCRX: Which Stock Should Value Investors Buy Now? Zacks +7.99%
Nov-26-19 02:29PM	Assertio Therapeutics to Present at the 31st Annual Piper Jaffray Healthcare Conference GlobeNewswire
Nov-13-19 12:58PM	Assertio Therapeutics to Present at the 2019 Stifel Healthcare Conference GlobeNewswire +11.25%
Nov-07-19 11:26AM	PDL BioPharma (PDLI) Q3 Earnings Beat, LENSAR Drives Sales Zacks
Nov-06-19 07:45PM	Assertio (ASRT) Surpasses Q3 Earnings Estimates Zacks -12.08%
04:05PM	Assertio Therapeutics Announces Third-Quarter 2019 Results GlobeNewswire
Nov-04-19 06:05AM	How Much Did Assertio Therapeutics, Inc.'s (NASDAQ:ASRT) CEO Pocket Last Year? Simply Wall St.
Oct-30-19 06:35PM	Ceridian HCM Holding, BJ's Wholesale Club Holdings Set to Join S&P MidCap 400; Oceaneering International, Covetrus to Join S&P SmallCap 600 PR Newswire
10:34AM	Analysts Estimate Assertio (ASRT) to Report a Decline in Earnings: What to Look Out for Zacks
Oct-23-19 09:05AM	Assertio Therapeutics to Report Third-Quarter 2019 Financial Results After the Close of Markets on Wednesday, November 6, 2019 GlobeNewswire
Oct-22-19 07:51AM	The Daily Biotech Pulse: Biogen Alzheimer's Program Back On Track, Novartis Reports Strong Quarter, Takeda In-Licenses Autoimmune Disorder Drug Benzinga
Oct-21-19 09:05AM	Assertio Therapeutics Provides Regulatory Update on Long-Acting Cosyntropin GlobeNewswire -28.13%
Oct-13-19 04:33PM	The Week Ahead In Biotech: FDA Decisions, Johnson & Johnson Among Big Pharma Earnings Benzinga
Oct-05-19 09:54AM	How Does Assertio Therapeutics, Inc. (NASDAQ:ASRT) Affect Your Portfolio Volatility? Simply Wall St.
Sep-30-19 12:35PM	Assertio Therapeutics Announces Appointment of Dr. David Wheadon to its Board of Directors GlobeNewswire
Sep-26-19 08:00AM	Assertio Therapeutics to Present at the Annual Cantor Fitzgerald Global Healthcare Conference GlobeNewswire
Sep-24-19 05:38PM	Medicenna Strengthens Board of Directors by Appointment of Seasoned Biopharma Executive Ms. Karen Dawes CNW Group
Sep-20-19 09:40AM	ASRT vs. ZTS: Which Stock Is the Better Value Option? Zacks
Sep-09-19 09:50AM	Top Ranked Value Stocks to Buy for September 9th Zacks
Sep-05-19 11:05AM	If You Had Bought Assertio Therapeutics (NASDAQ:ASRT) Stock Three Years Ago, You'd Be Sitting On A 94% Loss, Today Simply Wall St.
Sep-04-19 09:30AM	ASRT vs. ZTS: Which Stock Should Value Investors Buy Now? Zacks
Aug-20-19 08:00AM	Assertio Therapeutics to Present at the 17th Annual Morgan Stanley Global Healthcare Conference GlobeNewswire -16.87%
07:59AM	Assertio Therapeutics Enters Oversold Territory Zacks
Aug-19-19 09:30AM	ASRT vs. PCRX: Which Stock Is the Better Value Option? Zacks
Aug-12-19 09:15PM	Assertio Therapeutics Inc (ASRT) Director, President and CEO Arthur J Higgins Bought $77,000 of ... GuruFocus.com
Aug-09-19 09:28AM	Assertio Therapeutics Announces Exchange Offer of $200 Million of its Currently Outstanding 2.50% Convertible Notes Due 2021 GlobeNewswire -45.91%
Aug-08-19 11:24PM	Assertio Therapeutics, Inc (ASRT) Q2 2019 Earnings Call Transcript Motley Fool +5.64%
Aug-07-19 07:35PM	Assertio (ASRT) Q2 Earnings Beat Estimates Zacks
04:02PM	Assertio Therapeutics Announces Strong Second-Quarter 2019 Results GlobeNewswire
Aug-06-19 03:22PM	Is Assertio Therapeutics (NASDAQ:ASRT) A Risky Investment? Simply Wall St.
Jul-31-19 10:36AM	Assertio (ASRT) Earnings Expected to Grow: Should You Buy? Zacks
Jul-26-19 09:30AM	ASRT or AMRX: Which Is the Better Value Stock Right Now? Zacks
Jul-17-19 04:05PM	Assertio Therapeutics to Report Second Quarter 2019 Financial Results After The Close of Markets on Wednesday, August 7, 2019 GlobeNewswire -8.38%
Jul-01-19 08:39AM	La Jolla (LJPC) Secures Positive CHMP Opinion for Giapreza Zacks
Jun-23-19 08:53PM	Heres What Hedge Funds Think About Assertio Therapeutics, Inc. (ASRT) Insider Monkey
Jun-22-19 10:37AM	Have Insiders Been Buying Assertio Therapeutics, Inc. (NASDAQ:ASRT) Shares? Simply Wall St.
Jun-13-19 09:50AM	Savara Plunges on Failure of Late-Stage Study on Molgradex Zacks
May-20-19 10:28AM	ASSERTIO THERAPEUTICS Enters Oversold Territory Zacks
May-14-19 09:30AM	Is ASSERTIO THERAPEUTICS, INC (ASRT) Stock Outpacing Its Medical Peers This Year? Zacks
May-09-19 11:24AM	Assertio Therapeutics, Inc (ASRT) Q1 2019 Earnings Call Transcript Motley Fool
May-08-19 05:25PM	Assertio (ASRT) Tops Q1 Earnings and Revenue Estimates Zacks
04:17PM	Assertio: 1Q Earnings Snapshot Associated Press
04:02PM	Assertio Therapeutics Announces First-Quarter 2019 Financial Results GlobeNewswire
May-06-19 11:54AM	Assertio Therapeutics (ASRT) to Post Q1 Earnings: What's Up? Zacks
May-01-19 10:33AM	Analysts Estimate Assertio (ASRT) to Report a Decline in Earnings: What to Look Out for Zacks
Apr-24-19 04:46PM	Assertio Therapeutics to Report First Quarter 2019 Financial Results After The Close of Markets on Wednesday, May 8, 2019 GlobeNewswire
Apr-23-19 08:22AM	What Assertio Therapeutics, Inc.'s (NASDAQ:ASRT) ROE Can Tell Us Simply Wall St.
Apr-16-19 07:17PM	Achaogen (AKAO) Files for Bankruptcy, Shares Plunge 65% Zacks

Assertio Holdings, Inc., a specialty pharmaceutical company, provides medicines in neurology, orphan, and specialty areas in the United States. The company offers Gralise (gabapentin), a once daily product for the management of postherpetic neuralgia; CAMBIA (diclofenac potassium for oral solution), a non-steroidal anti-inflammatory drug for the acute treatment of migraine attacks; and Zipsor (diclofenac potassium liquid filled capsules), a non-steroidal anti-inflammatory drug for treating mild to moderate acute pain. It also provides NUCYNTA ER (tapentadol extended release tablet), a product for the management of pain severe enough to require daily, around-the-clock, and long term opioid treatment, including neuropathic pain related to diabetic peripheral neuropathy in adults; and NUCYNTA IR (tapentadol), a product for the management of moderate to severe acute pain in adults. In addition, the company offers long-acting cosyntropin, an alcohol-free formulation of synthetic adrenocorticotropic hormone. Assertio Therapeutics, Inc. has a collaboration and license agreement with Ironwood Pharmaceuticals, Inc. The company was formerly known as Assertio Therapeutics, Inc. and changed its name to Assertio Holdings, Inc. in May 2020. Assertio Holdings, Inc. was founded in 1995 and is headquartered in Lake Forest, Illinois.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
DAWES KAREN A	Director	May 08	Sale	0.79	15,834	12,531	84,589	May 11 08:23 PM
Bukofzer Stan	SVP, Chf Scitfc & Tech Officer	Apr 02	Option Exercise	0.00	25,370	0	70,349	Apr 03 06:50 PM
Galeota James JR	Director	Mar 30	Option Exercise	0.00	12,492	0	12,492	Mar 31 07:32 PM
Mason Heather L	Director	Feb 18	Option Exercise	0.00	14,394	0	14,394	Feb 19 05:00 PM
Peisert Daniel A.	SVP and CFO	Feb 12	Option Exercise	0.00	27,588	0	112,753	Feb 12 06:41 PM
Bukofzer Stan	SVP, Chf Scitfc & Tech Officer	Feb 12	Option Exercise	0.00	27,588	0	54,524	Feb 12 06:40 PM
HIGGINS ARTHUR J	Director, President and CEO	Feb 12	Option Exercise	0.00	97,412	0	275,747	Feb 12 06:41 PM
HIGGINS ARTHUR J	Director, President and CEO	Feb 06	Option Exercise	0.00	62,399	0	199,925	Feb 06 05:49 PM
Peisert Daniel A.	SVP and CFO	Feb 06	Option Exercise	0.00	6,700	0	87,483	Feb 06 05:49 PM
HIGGINS ARTHUR J	Director, President and CEO	Dec 01	Option Exercise	0.00	34,860	0	147,739	Dec 02 05:20 PM
Peisert Daniel A.	SVP and CFO	Dec 01	Option Exercise	0.00	8,359	0	83,232	Dec 02 05:20 PM
HIGGINS ARTHUR J	Director, President and CEO	Nov 12	Buy	0.73	25,000	18,250	112,879	Nov 12 04:36 PM
Peisert Daniel A.	SVP and CFO	Nov 11	Buy	0.73	10,000	7,259	74,873	Nov 12 04:36 PM
STAPLE PETER D	Director	Nov 11	Buy	0.71	13,900	9,911	13,900	Nov 12 04:36 PM

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience